Skip to content
← Back to this collection

PUBLICATIONS · 19747360

Clofarabine, cyclophosphamide and etoposide as single-course re-induction therapy for children with refractory/multiple relapsed acute lymphoblastic leukaemia.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Br J Haematol
Publication date
2009 Nov
First author
Locatelli F

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Locatelli F
      type
      Author
    2. name
      Testi AM
      type
      Author
    3. name
      Bernardo ME
      type
      Author
    4. name
      Rizzari C
      type
      Author
    5. name
      Bertaina A
      type
      Author
    6. name
      Merli P
      type
      Author
    7. name
      Pession A
      type
      Author
    8. name
      Giraldi E
      type
      Author
    9. name
      Parasole R
      type
      Author
    10. name
      Barberi W
      type
      Author
    11. name
      Zecca M
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Locatelli F
      type
      Author
    2. name
      Testi AM
      type
      Author
    3. name
      Bernardo ME
      type
      Author
    4. name
      Rizzari C
      type
      Author
    5. name
      Bertaina A
      type
      Author
    6. name
      Merli P
      type
      Author
    7. name
      Pession A
      type
      Author
    8. name
      Giraldi E
      type
      Author
    9. name
      Parasole R
      type
      Author
    10. name
      Barberi W
      type
      Author
    11. name
      Zecca M
      type
      Author
    bibliography ids
    1. nci-bib-6773cdd04c89809c065a6e4d
    book metadata
    content sha256
    23c6a2220f73a59f9e3e9b6523db9b6bb45be6ec5b56a87e75d397b998bca0e5
    document type
    citation
    dois
    1. 10.1111/j.1365-2141.2009.07882.x
    electronic publication date
    display
    2009 Aug 29
    precision
    day
    year
    2009
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:19747360
    immutable id
    pubmed:19747360@23c6a2220f73a59f9e3e9b6523db9b6bb45be6ec5b56a87e75d397b998bca0e5
    journal
    abbreviation
    Br J Haematol
    issn electronic
    1365-2141
    issn print
    0007-1048
    issue
    3
    name
    British journal of haematology
    nlm unique id
    0372544
    pages
    371-8
    volume
    147
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      19747360
      provenance
      batch id
      0706b5111d1451f52f74
      provider
      NCBI PubMed ESummary
      record sha256
      dc41bf5772e73c75f331ac10738c382867ce450ba271fd1580523219bb5ff2e7
      response sha256
      98b7635e326dbc32198e6976da57b1b6c18df77505740dee0ce67d80260cda70
      retrieved at
      2026-09-09T23:46:29.215195+00:00
      publication date
      display
      2009 Nov
      precision
      month
      year
      2009
      publication types
      1. Clinical Trial
      2. Journal Article
      3. Multicenter Study
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/19747360/
      title
      Clofarabine, cyclophosphamide and etoposide as single-course re-induction therapy for children with refractory/multiple relapsed acute lymphoblastic leukaemia.

      Preserved source evidence · Not medical advice